Search Results - "Zaidi, Omer"

Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction by Greene, Stephen J., Tan, Xi, Yeh, Yu-Chen, Bernauer, Mark, Zaidi, Omer, Yang, Mei, Butler, Javed

“…In clinical practice, many patients with heart failure with reduced ejection fraction (HFrEF) are either not prescribed guideline-directed medical therapies…”
Get full text

Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries by Zaidi, Omer, Du, Fen, Tang, Zhaoli, Bhattacharjee, Sandipan, Pareja, Kristin

“…Immunoglobulin type A (IgA) nephropathy is the most common primary glomerulonephritis (GN) worldwide with higher rates in East and Pacific Asia compared to…”
Get full text

Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region by Phongsamart, Wanatpreeya, Lou, Pei-Jen, Sukarom, Isaya, Wu, Ying-Hui, Zaidi, Omer, Du, Frieda, Simon, Alyssa, Bernauer, Mark

“…There is limited literature on current human papillomavirus (HPV) vaccination in the Asia-Pacific region. This integrative literature review was conducted to…”
Get full text

Systematic literature review on the clinical and economic burden of human papillomavirus–related diseases in select areas in the Asia-Pacific region by Lou, Pei-Jen, Phongsamart, Wanatpreeya, Sukarom, Isaya, Wu, Ying-Hui, Zaidi, Omer, Du, Frieda, Simon, Alyssa, Bernauer, Mark

“…Compared with Europe and America, adoption of human papillomavirus (HPV) vaccination into national immunization programs across the Asia-Pacific (AP) region…”
Get full text

Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data by Yang, Jingyan, Liu, Rongzhe, Granghaud, Anna, Zaidi, Omer, Stephens, Jennifer

“…NYVEPRIA, a pegfilgrastim (a long-acting granulocyte colony-stimulating factor [G-CSF]) biosimilar, was recently recommended for marketing authorization in…”
Get more information

Efficacy Outcomes of Treatments for Double Relapsed/Refractory Follicular Lymphoma (R/R FL): A Systematic Literature Review by Kahl, Brad S., Patel, Anik R., Zaidi, Omer, Snedecor, Sonya J., Purdum, Anna G.

“…ABSTRACT Introduction:Patients with indolent non-Hodgkin lymphomas (iNHL), including follicular lymphoma (FL), have high response to first-line treatment…”
Get full text

Real-world cost–effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia by Cornes, Paul, Kelton, John, Liu, Rongzhe, Zaidi, Omer, Stephens, Jennifer, Yang, Jingyan

“…Real-world data suggests superiority of pegfilgrastim (PEG) over filgrastim (FIL) in reducing the incidence of chemotherapy-induced febrile neutropenia (FN),…”
Get full text

Poster: IBCL-425 Disease Burden and Treatment Patterns of Relapsed/Refractory Follicular Lymphoma: A Systematic Literature Review by Chang, Chunlan, Fraser, Cindy Duval, Zaidi, Omer, Simon, Alyssa, Bernauer, Mark, Zhao, Yang

Get full text

IBCL-425 Disease Burden and Treatment Patterns of Relapsed/Refractory Follicular Lymphoma: A Systematic Literature Review by Chang, Chunlan, Fraser, Cindy Duval, Zaidi, Omer, Simon, Alyssa, Bernauer, Mark, Zhao, Yang

Get full text

Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas by Tantawichien, Terapong, Hsu, Li Yang, Zaidi, Omer, Bernauer, Mark, Du, Frieda, Yamada, Eriko, Kim, Jin Oh, Sukarom, Isaya

“…Pneumococcal diseases are common and cause significant morbidity and mortality, with higher rates especially in developing areas including many in the…”
Get more information

The Real-World Incidence of Relapse in Acute Myeloid Leukemia (AML): A Systematic Literature Review (SLR) by Oliva, Esther N., Franek, Jacob, Patel, Dipen, Zaidi, Omer, Nehme, Salem Abi, Almeida, Antonio M.

“…Background: AML is a hematologic malignancy with a high rate of treatment failure due in part to high relapse of the disease following initial or subsequent…”
Get full text

THU394 Disease Burden Of X-Linked Hypophosphatemia Focused On The United States And Canada: A Targeted Literature Review by Li, Zhiyi, Zaidi, Omer, Chukwu, Chinenye, Heerssen, Heather, Zhao, Yang, Dale, Angie, Bernauer, Mark

“…Abstract Disclosure: Z. Li: Employee; Self; Employee of Kyowa Kirin, Inc., Princeton, NJ, USA. O. Zaidi: Other; Self; Employee of OPEN Health and received…”
Get full text

Current Treatment Paradigms and Clinical Outcomes in Oligometastatic Prostate Cancer Patients: A Targeted Literature Review by Antonarakis, Emmanuel S., Shui, Irene M., Zaidi, Omer, Bernauer, Mark, Gratzke, Christian

“…This targeted review summarizes the epidemiology, disease definitions, mortality/survival outcomes, and treatment characteristics in both clinical trial and…”
Get full text

Efficacy of Systemic Therapies for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (R/R iNHL): A Systematic Literature Review (SLR) by Bachy, Emmanuel, Fox, Christopher P., Arcaini, Luca, Hernandez-Ilizaliturri, Francisco J., Howlett, Susannah, Snedecor, Sonya J., Franek, Jacob, Zaidi, Omer, Tabah, Ashley

“…▪ Introduction: Indolent non-Hodgkin lymphomas (iNHL), including follicular lymphoma (FL) and marginal zone lymphoma (MZL), are slow-growing lymphoid…”
Get full text

A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia by Oliva, Esther Natalie, Ronnebaum, Sarah M, Zaidi, Omer, Patel, Dipen A, Nehme, Salem Abi, Chen, Clara, Almeida, Antonio M

“…Acute myeloid leukemia (AML) is a rapidly progressive hematological malignancy that is difficult to cure. The prognosis is poor and treatment options are…”
Get full text